Calumet (CLMT) Projected to Post Quarterly Earnings on Friday

Calumet (NASDAQ:CLMT) is projected to issue its Q4 2025 results before the market opens on Friday, February 27th. Analysts expect the company to announce earnings of ($0.67) per share and revenue of $1.0446 billion for the quarter. Parties can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Friday, February 27, 2026 at 9:00 AM ET.

Calumet Stock Down 0.4%

Shares of CLMT stock opened at $29.39 on Friday. Calumet has a 12 month low of $7.68 and a 12 month high of $29.92. The business’s 50 day moving average is $21.99 and its two-hundred day moving average is $19.33. The company has a market cap of $2.55 billion, a PE ratio of -68.35 and a beta of 1.24.

Institutional Trading of Calumet

A number of large investors have recently made changes to their positions in CLMT. Invesco Ltd. raised its stake in Calumet by 13.6% during the 4th quarter. Invesco Ltd. now owns 123,607 shares of the oil and gas company’s stock worth $2,456,000 after buying an additional 14,769 shares during the period. Numerai GP LLC bought a new stake in shares of Calumet in the fourth quarter worth about $620,000. Millennium Management LLC raised its position in shares of Calumet by 119.9% during the fourth quarter. Millennium Management LLC now owns 13,902 shares of the oil and gas company’s stock worth $276,000 after purchasing an additional 83,844 shares during the period. Trexquant Investment LP raised its position in shares of Calumet by 45.5% during the fourth quarter. Trexquant Investment LP now owns 265,637 shares of the oil and gas company’s stock worth $5,278,000 after purchasing an additional 83,093 shares during the period. Finally, Laurion Capital Management LP bought a new position in shares of Calumet during the 4th quarter valued at about $748,000. Institutional investors own 34.41% of the company’s stock.

Analysts Set New Price Targets

Several analysts recently issued reports on the stock. HC Wainwright reaffirmed a “buy” rating and set a $33.00 price objective on shares of Calumet in a report on Monday, November 10th. UBS Group restated a “neutral” rating and set a $26.00 price target on shares of Calumet in a report on Friday, February 13th. The Goldman Sachs Group raised their price target on Calumet from $20.00 to $24.00 and gave the company a “buy” rating in a research report on Friday, January 30th. Wall Street Zen cut Calumet from a “buy” rating to a “hold” rating in a research report on Sunday, December 14th. Finally, TD Cowen restated a “hold” rating on shares of Calumet in a research note on Thursday, January 29th. Four analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $22.83.

About Calumet

Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.

Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.